Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac Kv4.3 (Ito) Channel Isoforms
Cardiac Kv4.3 channels contribute to the transient outward K+ current, Ito, during early repolarization of the cardiac action potential. Two different isoforms of Kv4.3 are present in the human ventricle and exhibit differential remodeling in heart failure (HF). Cardioselective betablockers are a cornerstone of HF with reduced ejection fraction therapy as well as ventricular arrhythmia treatment. In this study we examined pharmacological effects of betablockers on both Kv4.3 isoforms to explore their potential for isoform-specific therapy. Kv4.3 isoforms were expressed in Xenopus laevis oocytes and incubated with the respective betablockers. Dose-dependency and biophysical characteristics were examined. HEK 293T-cells were transfected with the two Kv4.3 isoforms and analyzed with Western blots. Carvedilol (100 µM) blocked Kv4.3 L by 77 ± 2% and Kv4.3 S by 67 ± 6%, respectively. Metoprolol (100 µM) was less effective with inhibition of 37 ± 3% (Kv4.3 L) and 35 ± 4% (Kv4.3 S). Bisoprolol showed no inhibitory effect. Current reduction was not caused by changes in Kv4.3 protein expression. Carvedilol inhibited Kv4.3 channels at physiologically relevant concentrations, affecting both isoforms. Metoprolol showed a weaker blocking effect and bisoprolol did not exert an effect on Kv4.3. Blockade of repolarizing Kv4.3 channels by carvedilol and metoprolol extend their pharmacological mechanism of action, potentially contributing beneficial antiarrhythmic effects in normal and failing hearts.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
International journal of molecular sciences - 24(2023), 18 vom: 08. Sept. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rahm, Ann-Kathrin [VerfasserIn] |
---|
Links: |
---|
Themen: |
0K47UL67F2 |
---|
Anmerkungen: |
Date Completed 29.09.2023 Date Revised 03.10.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/ijms241813842 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362584125 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM362584125 | ||
003 | DE-627 | ||
005 | 20231226091537.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ijms241813842 |2 doi | |
028 | 5 | 2 | |a pubmed24n1208.xml |
035 | |a (DE-627)NLM362584125 | ||
035 | |a (NLM)37762145 | ||
035 | |a (PII)13842 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rahm, Ann-Kathrin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac Kv4.3 (Ito) Channel Isoforms |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.09.2023 | ||
500 | |a Date Revised 03.10.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Cardiac Kv4.3 channels contribute to the transient outward K+ current, Ito, during early repolarization of the cardiac action potential. Two different isoforms of Kv4.3 are present in the human ventricle and exhibit differential remodeling in heart failure (HF). Cardioselective betablockers are a cornerstone of HF with reduced ejection fraction therapy as well as ventricular arrhythmia treatment. In this study we examined pharmacological effects of betablockers on both Kv4.3 isoforms to explore their potential for isoform-specific therapy. Kv4.3 isoforms were expressed in Xenopus laevis oocytes and incubated with the respective betablockers. Dose-dependency and biophysical characteristics were examined. HEK 293T-cells were transfected with the two Kv4.3 isoforms and analyzed with Western blots. Carvedilol (100 µM) blocked Kv4.3 L by 77 ± 2% and Kv4.3 S by 67 ± 6%, respectively. Metoprolol (100 µM) was less effective with inhibition of 37 ± 3% (Kv4.3 L) and 35 ± 4% (Kv4.3 S). Bisoprolol showed no inhibitory effect. Current reduction was not caused by changes in Kv4.3 protein expression. Carvedilol inhibited Kv4.3 channels at physiologically relevant concentrations, affecting both isoforms. Metoprolol showed a weaker blocking effect and bisoprolol did not exert an effect on Kv4.3. Blockade of repolarizing Kv4.3 channels by carvedilol and metoprolol extend their pharmacological mechanism of action, potentially contributing beneficial antiarrhythmic effects in normal and failing hearts | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Ito | |
650 | 4 | |a Kv4.3 | |
650 | 4 | |a antiarrhythmic effects | |
650 | 4 | |a betablocker | |
650 | 4 | |a heart failure | |
650 | 7 | |a Metoprolol |2 NLM | |
650 | 7 | |a GEB06NHM23 |2 NLM | |
650 | 7 | |a Bisoprolol |2 NLM | |
650 | 7 | |a Y41JS2NL6U |2 NLM | |
650 | 7 | |a Carvedilol |2 NLM | |
650 | 7 | |a 0K47UL67F2 |2 NLM | |
650 | 7 | |a Protein Isoforms |2 NLM | |
700 | 1 | |a Hackbarth, Juline |e verfasserin |4 aut | |
700 | 1 | |a Müller, Mara E |e verfasserin |4 aut | |
700 | 1 | |a Pfeiffer, Julia |e verfasserin |4 aut | |
700 | 1 | |a Gampp, Heike |e verfasserin |4 aut | |
700 | 1 | |a Petersenn, Finn |e verfasserin |4 aut | |
700 | 1 | |a Rivinius, Rasmus |e verfasserin |4 aut | |
700 | 1 | |a Frey, Norbert |e verfasserin |4 aut | |
700 | 1 | |a Lugenbiel, Patrick |e verfasserin |4 aut | |
700 | 1 | |a Thomas, Dierk |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 24(2023), 18 vom: 08. Sept. |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g number:18 |g day:08 |g month:09 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms241813842 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |e 18 |b 08 |c 09 |